Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering
February 01, 2024 06:00 AM Eastern Standard Time SAN DIEGO–(BUSINESS WIRE)–Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on harnessing the power of trained immunity for the…